Some of the country's largest drugmakers could be impacted by President Trump's tariffs, announced on Wednesday from the Rose Garden. That includes a 10% baseline tariff, but not the 20% reciprocal ...

A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

Siemens’ role in providing advanced technology and expertise in industrial applications is poised to have a long-lasting ...

Johnson & Johnson has officially started construction on a $2 billion manufacturing campus in Wilson, North Carolina, marking ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

As part of a new $55 billion investment nationally, pharmaceutical giant Johnson & Johnson is investing in a manufacturing ...

Johnson & Johnson (NYSE: JNJ), has broken ground on a $2 billion pharmaceutical manufacturing facility in Wilson, about 50 ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United States, if required, as the Trump administration threatens numerous tariffs ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Advancements in drug manufacturing technologies are reshaping global regulatory frameworks. This shift is largely driven by the integration of artificial intelligence (AI)-powered models, cloud ...

Nigeria’s indigenous pharmaceutical companies are stepping up to fill the gaps left by departing multinationals, aggressively ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, with the goal of reshoring drug production by American biopharmas, industry leaders ...